What is the recommended dose of thiamine (Vitamin B1) for managing alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thiamine Dosing in Alcohol Withdrawal

All patients with alcohol withdrawal syndrome should receive thiamine 100-300 mg/day for prevention of Wernicke's encephalopathy, with higher doses of 100-500 mg/day required if Wernicke's encephalopathy is already established. 1

Dosing Algorithm Based on Clinical Presentation

For Prevention of Wernicke's Encephalopathy (Standard Alcohol Withdrawal)

  • Administer 100-300 mg/day thiamine for 4-12 weeks 1, 2
  • The parenteral route (IV or IM) is strongly preferred initially due to poor gastrointestinal absorption in alcoholic patients 2
  • Continue for 2-3 months following resolution of withdrawal symptoms 1

For Established Wernicke's Encephalopathy

  • Administer 100-500 mg/day thiamine for 12-24 weeks 1, 2
  • The FDA label recommends an initial IV dose of 100 mg, followed by IM doses of 50-100 mg daily until regular diet is resumed 3
  • Recent evidence supports even higher doses (500 mg) when symptoms persist on lower doses, with rapid resolution of altered mental status and ophthalmoplegia 4

For High-Risk Patients Receiving IV Dextrose

  • Give 100 mg thiamine in each of the first few liters of IV fluid to prevent precipitating acute heart failure 3
  • This is critical because IV glucose can precipitate acute thiamine deficiency 1, 2

Route of Administration

Thiamine must be given BEFORE any glucose-containing fluids to prevent precipitating acute Wernicke's encephalopathy 1, 2

  • Parenteral (IV or IM) route is preferred initially over oral administration due to unreliable gastrointestinal absorption in alcoholic patients 2
  • Transition to oral thiamine (250-300 mg/day) after acute phase for maintenance 5

Safety Considerations

The risk of anaphylactic shock from parenteral thiamine is extremely low (less than 1 in 100,000), making the benefits far outweigh the risks 6

  • In "wet" beriberi with myocardial failure, thiamine must be administered slowly by IV route 3
  • All patients experienced symptom improvement across a wide range of doses (100-1500 mg) with minimal adverse events 7
  • High-dose IV thiamine (≥500 mg) is reliable and low-risk even at these elevated doses 4

Common Pitfalls to Avoid

  • Never administer glucose-containing IV fluids before thiamine replacement - this can precipitate acute Wernicke's encephalopathy 1, 2, 3
  • Do not rely on oral thiamine alone in acute withdrawal - absorption is compromised in alcoholic patients 2
  • Do not underdose - doses of at least 100 mg are required, and higher doses (200-500 mg three times daily) are recommended for established Wernicke's encephalopathy 5
  • Do not delay treatment - Wernicke's encephalopathy has 20% acute mortality and is frequently underdiagnosed and undertreated 5, 6

Duration of Treatment

  • Acute phase: 4-12 weeks for prevention 1, 2
  • Established Wernicke's encephalopathy: 12-24 weeks 1
  • Maintenance after withdrawal resolution: Continue for 2-3 months 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Alcohol Dependence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Thiamine (vitamin B1) treatment in patients with alcohol dependence].

Presse medicale (Paris, France : 1983), 2017

Research

[Thiamine treatment in psychiatry and neurology].

Fortschritte der Neurologie-Psychiatrie, 2000

Research

Thiamine Dosing for the Treatment of Alcohol-Induced Wernicke's Encephalopathy: A Review of the Literature.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.